FDA Drug Application (017557) for DANOCRINE by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number017557
Product Number002
FormCAPSULE;ORAL
Dosage200MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDANOCRINE
Active IngredientDANAZOL

Active IngredientCount
List of drugs with Active Ingredient DANAZOL2


Back to FDA Applications sponsored by SANOFI AVENTIS US